Formulation for treating thalassemia and a process for preparing

Details Formulation for treating thalassemia and a process for preparing Formulation for treating thalassemia and a process for preparing

1995-07-11

1997-09-09

Venkat, Jyothsna

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

4241951, A61K 914

Patent

active

056653921

ABSTRACT:
A pharmaceutical formulation useful for treating patients suffering from thalassemia, which comprises powder of Anemonin Pretensis in an amount in the range of 0.02 to 0.12 wt % of the formulation, quinine sulphate in an amount in the range of 0.0005 to 0.003 wt % of the formulation, distilled or demineralised water in an amount in the range of 0 to 40 wt % of the formulation and, ethanol in an amount in the range of 99.88 to 60 wt % of the formulation; and a process for preparing the formulation by mixing the above ingredients.

REFERENCES:
The Marshall Cavendish Illustrated Encyclopedia of Family Health; Thalassaemia; pp. 2373-2374.
Anemones, p. 114.
Clinical Trials of Deferiprone (L1), A.V. Foffbrand (Royal Free Hospital, pp. 2-3, Issue No. 61.
Desferal, p. 601.
C. Hershko, Iron-Chelating Therapy, vol. 26, Issue 4 (1988), pp. 303-345.

Affiliated with

Also associated with

Rating

Formulation for treating thalassemia and a process for preparing does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulation for treating thalassemia and a process for preparing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation for treating thalassemia and a process for preparing will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-67835